Valeant CEO to take medical leave after being hospitalized with pneumonia

LAVAL, Que. -- Embattled pharmaceutical firm Valeant International says its chief executive is taking a medical leave of absence.

The Quebec-based company previously revealed that Michael Pearson was hospitalized last week with what it described as a severe case of pneumonia.

See Full Article

Valeant (TSX:VRX) did not offer updates on Pearson's condition, but says his leave of absence takes effect immediately.

Valeant says Pearson's duties will be shared on an interim basis between General Council Robert Chai-Onn, Company Group Chairman Ari Kellen, and Chief Financial Officer Robert Rosiello.

Valeant has been facing a series of scandals that have slashed its stock price by more than half since record highs posted in August.

The company is facing a congressional investigation in the U.S. over its pricing practices and has been forced to revise its 2016 outlook after ending a drug distribution agreement with the controversial Philidor mail-order pharmacy.

Pearson himself had been facing criticism for Valeant's share price collapse and recently struck a defiant tone after calls for his dismissal surfaced.

"If the board wants to fire me they are welcome to fire me, but until they do we're going to get through this thing," Pearson told investors during a Dec. 16 webcast.

Valeant said the October split from specialty pharmaceutical partner Philidor Rx Services caused a big short-term disruption to its business that would reduce its expectations for the fourth quarter and 2015 as a whole.

But Pearson had also indicated that a new distribution agreement with major U.S. drug store chain Walgreens had set the company back on the road to recovery.

Pearson, 56, joined Valeant in 2008 after a 23-year career with the consulting firm McKinsey & Co., for which he served as head of its global pharmaceutical practice.

He used a string of acquisitions to turn a relatively small business that made generic drugs and chronic illness treatments into a major pharmaceutical company. Valeant, formerly based in California, combined with Wellbutrin XL maker Biovail in 2010 to form Laval, Quebec-based Valeant Pharmaceuticals International Inc. Its sales climbed from US$2.46 billion in 2011 to an expected US$10.4 billion to US$10.5 billion for this year.

Valeant shares closed at $157.68 on Thursday, the most recent day on which the Toronto Stock Exchange was open for trading.

That figure was well up from a 52-week low of $92.65 but well shy of a historic high of $347.84 in August.



Advertisements

Latest Economic News

  • Trudeau defends Bombardier aid after executive compensation rose last year

    Economic CTV News
    BRAMPTON, Ont. -- Prime Minister Justin Trudeau is defending his government's decision to provide federal assistance to Bombardier after the company's senior executives saw their compensation rise by nearly 50 per cent last year. After touring a Magna auto parts facility in Brampton, Ont. Source
  • GDP numbers Friday expected to show economy started 2017 strong

    Economic CBC News
    Some economists are revising their forecasts upward for Canadian first-quarter gross domestic product growth, ahead of the Friday release of figures for January. The market consensus for January calls for a growth rate of 0.3 per cent, which would match the December report. Source
  • Brad Wall to meet with Trump cabinet members when he heads to Washington

    Economic CTV News
    REGINA -- Saskatchewan Premier Brad Wall says he has landed meetings with two members of Donald Trump's cabinet next week, including the president's point man on NAFTA. Wall is scheduled to be in Washington and says he will sit down with Secretary of Energy Rick Perry and Secretary of Commerce Wilbur Ross, the man tapped by Trump to deliver on a promise to renegotiate the North American Free Trade Agreement. Source
  • Alberta premier checking to see if Saskatchewan's Wall breaking free-trade deal

    Economic CTV News
    RED DEER, Alta. -- Alberta Premier Rachel Notley says she is looking at whether Saskatchewan's Brad Wall is breaking regional free-trade rules by offering incentives for oil and gas firms to move to his province. Source
  • McDonald's opts for fresh beef, not frozen, for some burgers soon

    Economic CBC News
    Coming soon to McDonald's: Fresh beef. The fast food giant said Thursday that it will swap frozen beef patties for fresh ones in its Quarter Pounder burgers by sometime next year at most of its U.S. Source
  • Environmental groups challenge Keystone XL pipeline approval

    Economic CBC News
    A coalition of environmental groups challenged the U.S. federal permit for the Keystone XL oil pipeline in court on Thursday because they say additional environmental scrutiny is needed. The Sierra Club, Natural Resources Defense Council and other groups say the initial environmental review completed in 2014 is inadequate and outdated, and that it underestimated how much the pipeline would encourage tar sands oil production in Canada. Source
  • Cenovus shares fall in wake of $17.7B oilsands purchase

    Economic CBC News
    Shares in Cenovus Energy were down 11 per cent shortly after markets opened Thursday following its announcement to acquire Canadian assets belonging to Houston-based ConocoPhillips.Cenovus Energy buying most of ConocoPhillips' Canadian assets for $17.7BUnder the $17.7 billion deal, the Calgary-based energy company would take over most of ConocoPhillips's investments in Canada in what is the latest mega oilsands sale by a major foreign oil and gas producer. Source
  • Is Toronto's housing market in a bubble? Not quite, analyst says

    Economic CTV News
    Despite a recent declaration by Bank of Montreal Chief Economist Douglas Porter that Toronto’s red-hot housing market is indeed in a “bubble,” other economists have been hesitant to use the controversial label to describe the city’s current real estate boom. Source
  • CIBC boosts takeover offer for PrivateBancorp to more than $6B

    Economic CBC News
    Shares of Canadian Imperial Bank of Commerce traded lower Thursday after the bank boosted its takeover bid for PrivateBancorp by 20 per cent. Under the terms of a new takeover agreement that has approved by the boards of directors of both firms, the deal values Chicago-based PrivateBancorp at approximately $6.6 billion Cdn, or $60.92 US per share, Source
  • Air Canada lawsuit accuses Airbus of negligence in Halifax crash landing

    Economic CTV News
    HALIFAX - Air Canada is claiming a French aircraft manufacturer's negligence contributed to a crash landing at Halifax Stanfield International Airport two years ago. The Canadian airline is suing Airbus SAS, saying the company failed to identify shortcomings of the Airbus 320. Source